Meghan Scanlon

CIK 1801586 · SVP,Pres,Urology Pelvic Health · last filed 2025-04-21

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

2

Total Filings

24

Lifetime Open-Market Net

-$1.35M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Paragon 28, Inc. (FNA) Delisted Director 0 $13.09 $0 $0 4 2025-04-21
BOSTON SCIENTIFIC CORP (BSXw) Delisted SVP,Pres,Urology Pelvic Health 24,461 -$1.35M 20 2022-05-02

Recent Filings · Page 3 of 3

24 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2020-05-04 BOSTON SCIENTIFIC CORP (BSXw) Delisted Mixed +1,435 -$22.5K EDGAR
2020-03-03 BOSTON SCIENTIFIC CORP (BSXw) Delisted Mixed +709 -$11.6K EDGAR
2020-02-24 BOSTON SCIENTIFIC CORP (BSXw) Delisted Mixed +2,210 -$40.7K EDGAR
2020-02-19 BOSTON SCIENTIFIC CORP (BSXw) Delisted Grant (A) $0 EDGAR
Showing 2124 of 24
Page 3 of 3
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.